These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9925191)

  • 1. Diagnostic subgrouping of depressed patients by principal component analysis and visualized pattern recognition.
    Wahlund B; Sääf J; Grahn H; Wetterberg L
    Psychiatry Res; 1998 Dec; 81(3):393-401. PubMed ID: 9925191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
    Wahlund B; Sääf J; Wetterberg L
    Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affective disorder subtyped by psychomotor symptoms, monoamine oxidase, melatonin and cortisol: identification of patients with latent bipolar disorder.
    Wahlund B; Grahn H; Sääf J; Wetterberg L
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(5):215-24. PubMed ID: 9840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical symptoms and platelet monoamine oxidase in subgroups and different states of affective disorders.
    Wahlund B; Sääf J; Wetterberg L
    J Affect Disord; 1995 Oct; 35(1-2):75-87. PubMed ID: 8557890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY; Lowy MT; Locascio JJ
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
    Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
    Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT; Marciniak R
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
    Samson JA; Gudeman JE; Schatzberg AF; Kizuka PP; Orsulak PJ; Cole JO; Schildkraut JJ
    J Psychiatr Res; 1985; 19(4):547-55. PubMed ID: 4078757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
    Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
    Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
    [No Abstract]   [Full Text] [Related]  

  • 14. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin uptake in blood platelets and the dexamethasone suppression test in depressed patients.
    Meltzer HY; Arora RC; Tricou BJ; Fang VS
    Psychiatry Res; 1983 Jan; 8(1):41-7. PubMed ID: 6572986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.
    Rothschild AJ; Benes F; Hebben N; Woods B; Luciana M; Bakanas E; Samson JA; Schatzberg AF
    Biol Psychiatry; 1989 Oct; 26(6):565-75. PubMed ID: 2790096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
    Sato T; Bottlender R; Kleindienst N; Möller HJ
    J Affect Disord; 2005 Feb; 84(2-3):187-96. PubMed ID: 15708416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine challenge studies in puerperal psychoses. Dexamethasone suppression and TRH stimulation.
    Paykel ES; del Campo AM; White W; Horton R
    Br J Psychiatry; 1991 Aug; 159():262-6. PubMed ID: 1773243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.
    Angst J; Preisig M
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(1):5-16. PubMed ID: 7792568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet MAO activity in clinical subtypes of depression and DST suppression.
    Poirier MF; Lôo H; Mitrani N; Benkelfat C; Askienazy S; Le Fur G
    Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.